Clinical Trials
5 trialsNCT01432951 2020-10-12
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma
Eli Lilly and Company
Phase 1 Completed
NCT01388335 2020-07-01
A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin
Eli Lilly and Company
Phase 1 Completed
NCT00108056 2019-12-05
Enzastaurin to Treat Recurrent Brain Tumor
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT01445119 2013-08-28
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
Eli Lilly and Company
Phase 1 Completed
NCT00452257 2009-03-19
A Study of Enzastaurin in Patients With Leukemia
Eli Lilly and Company
Phase 1 Completed